comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Unveiling Tirzepatide's Therapeutic Spectrum: A Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, Health Cardiovascular, Kidney, and Safety Outcomes

However, it is essential to consult with a healthcare professional before starting any new supplement regimen, as berberine may interact with certain medications and have the potential for side effects if not used appropriately

Umapathysivam MM, Lee MY, Jones KL, Annink CE, Cousins CE, Trahair LG, et al

As we follow long-term outcomes of current therapies with new medications coming to market, it will be crucial to continue to evaluate lipid-specific outcomes that play a role in the overall cardiovascular benefits of GLP-1RA and other highly effective anti-obesity medications

The primary outcome was gestational weight gain, calculated as the difference between the last recorded weight within 1 week of delivery and prepregnancy weight